STOCKHOLDER AGREEMENTStockholder Agreement • October 31st, 2018 • Ophthotech Corp. • Pharmaceutical preparations • Delaware
THIS STOCKHOLDER AGREEMENT (“Agreement”) is made as of October 30, 2018, by and among Ophthotech Corporation, a Delaware corporation (the “Company”); Versant Venture Capital IV, L.P. and Versant Side Fund IV, L.P. (collectively, “Versant”); and, solely for purposes of being bound by Section 3.2 and Article IV, Versant Venture Management, LLC.
AGREEMENT AND PLAN OF MERGER by and among OPHTHOTECH CORPORATION, ORION OPHTHALMOLOGY MERGER SUB, INC., ORION OPHTHALMOLOGY LLC, INCEPTION 4, INC., and, SOLELY IN ITS CAPACITY AS COMPANY EQUITYHOLDER REPRESENTATIVE, FORTIS ADVISORS LLC Dated as of...Agreement and Plan of Merger • October 31st, 2018 • Ophthotech Corp. • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is entered into as of October 30, 2018, by and among: Ophthotech Corporation, a Delaware corporation (the “Buyer”); Orion Ophthalmology Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Buyer (the “Merger Subsidiary I”); Orion Ophthalmology LLC, a Delaware limited liability company and a direct wholly owned subsidiary of the Buyer (“Merger Subsidiary II”, and together with Merger Subsidiary I, the “Merger Subsidiaries”); Inception 4, Inc., a Delaware corporation (the “Company”); and, solely for purposes of being bound by Section 2.4, Section 2.6, Section 2.7, Section 2.8, Article V, Article VI, Article VII, and Article VIII, Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as the Company Equityholder Representative, (the “Company Equityholder Representative”).
